Managing the Economic Challenges in the Treatment of Heart Failure

Ileana L. Pina, Nihar R. Desai, Larry A. Allen, Paul Heidenreich

Research output: Contribution to journalReview article

Abstract

The economics of heart failure (HF) touches all patients with HF, their families, and the physicians and health systems that care for them. HF is specifically targeted by cost-reduction and care quality initiatives from the Centers for Medicare and Medicaid Services (CMS). The changing quality assessment and payment landscape is, and will continue to be, challenging for hospitals and HF specialists as they provide care for patients with this debilitating disease. Quality-based payment systems with evolving performance metrics are replacing traditional volume-based fee-for-service models. A critical objective of quality-based models is to improve care and reduce cost, but there are few data to support decision-making on how to improve. CMS payment programs and their implications for health systems treating HF were reviewed at a symposium at the Heart Failure Society of America conference in Nashville, Tennessee on September 15, 2018. This article constitutes the proceedings from that symposium.

Original languageEnglish (US)
Pages (from-to)476-483
Number of pages8
JournalProgress in Cardiovascular Diseases
Volume61
Issue number5-6
DOIs
StatePublished - Nov 1 2018

Fingerprint

Treatment Failure
Heart Failure
Economics
Centers for Medicare and Medicaid Services (U.S.)
Costs and Cost Analysis
Fee-for-Service Plans
Family Health
Quality of Health Care
Family Physicians
Touch
Decision Making
Patient Care
Delivery of Health Care
Health

Keywords

  • Cost-effectiveness
  • Economics
  • Heart failure
  • Medicare
  • Performance metrics
  • Readmission

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Managing the Economic Challenges in the Treatment of Heart Failure. / Pina, Ileana L.; Desai, Nihar R.; Allen, Larry A.; Heidenreich, Paul.

In: Progress in Cardiovascular Diseases, Vol. 61, No. 5-6, 01.11.2018, p. 476-483.

Research output: Contribution to journalReview article

Pina, Ileana L. ; Desai, Nihar R. ; Allen, Larry A. ; Heidenreich, Paul. / Managing the Economic Challenges in the Treatment of Heart Failure. In: Progress in Cardiovascular Diseases. 2018 ; Vol. 61, No. 5-6. pp. 476-483.
@article{46b7c649bc684dcfbf4ce38762b82fef,
title = "Managing the Economic Challenges in the Treatment of Heart Failure",
abstract = "The economics of heart failure (HF) touches all patients with HF, their families, and the physicians and health systems that care for them. HF is specifically targeted by cost-reduction and care quality initiatives from the Centers for Medicare and Medicaid Services (CMS). The changing quality assessment and payment landscape is, and will continue to be, challenging for hospitals and HF specialists as they provide care for patients with this debilitating disease. Quality-based payment systems with evolving performance metrics are replacing traditional volume-based fee-for-service models. A critical objective of quality-based models is to improve care and reduce cost, but there are few data to support decision-making on how to improve. CMS payment programs and their implications for health systems treating HF were reviewed at a symposium at the Heart Failure Society of America conference in Nashville, Tennessee on September 15, 2018. This article constitutes the proceedings from that symposium.",
keywords = "Cost-effectiveness, Economics, Heart failure, Medicare, Performance metrics, Readmission",
author = "Pina, {Ileana L.} and Desai, {Nihar R.} and Allen, {Larry A.} and Paul Heidenreich",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.pcad.2018.10.002",
language = "English (US)",
volume = "61",
pages = "476--483",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "5-6",

}

TY - JOUR

T1 - Managing the Economic Challenges in the Treatment of Heart Failure

AU - Pina, Ileana L.

AU - Desai, Nihar R.

AU - Allen, Larry A.

AU - Heidenreich, Paul

PY - 2018/11/1

Y1 - 2018/11/1

N2 - The economics of heart failure (HF) touches all patients with HF, their families, and the physicians and health systems that care for them. HF is specifically targeted by cost-reduction and care quality initiatives from the Centers for Medicare and Medicaid Services (CMS). The changing quality assessment and payment landscape is, and will continue to be, challenging for hospitals and HF specialists as they provide care for patients with this debilitating disease. Quality-based payment systems with evolving performance metrics are replacing traditional volume-based fee-for-service models. A critical objective of quality-based models is to improve care and reduce cost, but there are few data to support decision-making on how to improve. CMS payment programs and their implications for health systems treating HF were reviewed at a symposium at the Heart Failure Society of America conference in Nashville, Tennessee on September 15, 2018. This article constitutes the proceedings from that symposium.

AB - The economics of heart failure (HF) touches all patients with HF, their families, and the physicians and health systems that care for them. HF is specifically targeted by cost-reduction and care quality initiatives from the Centers for Medicare and Medicaid Services (CMS). The changing quality assessment and payment landscape is, and will continue to be, challenging for hospitals and HF specialists as they provide care for patients with this debilitating disease. Quality-based payment systems with evolving performance metrics are replacing traditional volume-based fee-for-service models. A critical objective of quality-based models is to improve care and reduce cost, but there are few data to support decision-making on how to improve. CMS payment programs and their implications for health systems treating HF were reviewed at a symposium at the Heart Failure Society of America conference in Nashville, Tennessee on September 15, 2018. This article constitutes the proceedings from that symposium.

KW - Cost-effectiveness

KW - Economics

KW - Heart failure

KW - Medicare

KW - Performance metrics

KW - Readmission

UR - http://www.scopus.com/inward/record.url?scp=85057027532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057027532&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2018.10.002

DO - 10.1016/j.pcad.2018.10.002

M3 - Review article

C2 - 30565564

AN - SCOPUS:85057027532

VL - 61

SP - 476

EP - 483

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 5-6

ER -